Radiotherapy is a powerful treatment strategy in patients with oncological diseases.
SUMMARY
As a consequence of the success of present-day cancer treatment, radiotherapy-induced vascular disease is emerging. This disease is caused by chronic inflammatory activation and is likely orchestrated in part by microRNAs. In irradiated versus nonirradiated conduit arteries from patients receiving microvascular free tissue transfer reconstructions, irradiation resulted in down-regulation of miR-29b and up-regulation of miR-146b. miR-29b affected inflammation and adverse wound healing through its targets pentraxin-3 and dipeptidylpeptidase 4. In vitro and in vivo, we showed that miR-29b overexpression therapy, through inhibition of pentraxin-3 and dipeptidyl-peptidase 4, could dampen the vascular inflammatory response. (1) . Despite being cancerfree, these patients have an increased risk of developing disease, ranging from cognitive impairment to heart failure, which can be attributed to previous cancer treatment (2) . In this context, radiation-induced vascular disease or radiation vasculopathy (vRTx) is an under-recognized problem with high-impact longterm sequelae, such as stroke and myocardial infarction (3) (4) (5) . In a manner proportional to radiation dosage and location, radiation therapy for breast cancer and Hodgkin lymphoma increases the risk for ischemic heart disease (6, 7) . In patients with head and neck cancer, carotid artery irradiation is a significant risk factor for carotid occlusive disease (5, 8, 9) . In free flap tissue transfer (FFT) surgery, a procedure involving transplantation of a vascularized tissue by using microvascular anastomosis to repair large defects after tumor resection, irradiation is reported to be a risk factor for vascular complications (10) (11) (12) .
The underlying pathophysiological mechanism of vRTx is a chronic inflammatory reaction initiated by the cellular response to ionizing radiation (13) have generated a great deal of attention because of their ability to critically regulate biological pathways (16) . miRNAs can inhibit gene expression at different levels by acting as master regulators of protein output (17) . miRNA modulation can influence and reverse disease processes and is used in preclinical as well as clinical studies (18,19).
The vasculature, a sensitive and tightly regulated system, is especially under miRNA control, with it being implicated and applied in various vascular diseases (20, 21) . Moreover, miRNAs play a crucial role in the DNA damage response (22) .
The current study investigated mechanisms through which down-regulation of miRNAs is involved in the adverse vascular response to irradiation and explored application of miRNA modulators as a therapeutic modality to reduce vRTx through dampening of the innate immune response and inhibition of an adverse healing response. Eken et al. Eken et al. Tables 1 to 3 Eken et al. Table 1 .
F E B R U
Among other miRNAs, miR-29b and miR-146b
were significantly deregulated in radiated tissue, miR-29b being decreased and miR-146b increased In radiated versus nonradiated tissue, PTX3 was the most profoundly upregulated miR-29b target ( Figure 1E ). DPP4 levels were also significantly higher in radiated tissue ( Figure 1F ). The predicted miR-29b gene target DPP4 (or CD26) is related to radiation injury and impaired wound healing (26) . With luciferase reporter assay, PTX3 and DPP4 were validated as miR-29b targets in HEK293 cells ( Figure 1G ).
In formalin-fixed, paraffin-embedded arterial tissue from a subset of patients, we could localize PTX3
and DPP4 protein expression in the intimal and Figures 2A and 2B ). HCtAEC proliferation was not significantly affected (Supplemental Figure 2C ). We measured miRNA and target gene expression 24 h after radiotherapy. In radiated 
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Eken et al. HCtASMCs, but not in HCtAECs, miR-29b was downregulated ( Figure 3A) . Radiated HCtAECs, but not HCtASMCs, exhibited up-regulation of miR-146b
( Figure 3B ). In HCtASMCs, expression of the miR-29b targets B4GALT5, DPP4, and COL1A1 was increased ( Figure 3C ). Although PTX3 gene expression was not increased, Western blotting showed elevated levels of PTX3 protein in these cells ( Figure 3D ). Figure 2D) .
MODULATION OF miR-29B ALTERS EXPRESSION OF INFLAMMATION-AND FIBROSIS-RELATED TARGETS
IN VITRO. Transfection of HCtASMCs with miR-29b mimics before radiotherapy completely abrogated soluble collagen secretion ( Figure 3E ) and decreased post-radiotherapy PTX3 expression, whereas antimiR-29b greatly stimulated PTX3 expression Eken et al.
( Figure 3F ). Interestingly, anti-miR-29b had no marked profibrotic effect in radiated cells, possibly because further suppression of already low miR-29b levels does not add to the fibrotic stimulus. In nonradiated cells, however, it induced a significant increase in soluble collagen production. Profibrotic DPP4 was not affected by miR-29b on the gene expression level, but Western blotting in HCtASMC lysates showed that expression of DPP4 protein was negatively affected by transfection with miR-29b mimics ( Figure 3G) . Because DPP4 has a soluble form, detectable in blood plasma and associated with a profibrotic phenotype, we assessed DPP4 expression in the supernatant of ECs or SMCs but could not detect the protein, independent of irradiation (data not shown).
MODULATION OF miR-29B AFFECTS TARGET PROTEIN EXPRESSION AND INFLAMMATION IN
VIVO. We subjected 12 Apoe -/-male mice to the 1 Â 14 Gy irradiation protocol, of which 6 received miR29b mimics 1 day before and 1 day after irradiation.
Target genes Ptx3 and Dpp4 were not significantly affected (Supplemental Figure 3A) Figure 3B) . Collectively, miR-29b mimics dampened the direct inflammatory reaction to irradiation, without affecting SMC content.
DISCUSSION
Irradiation is an important risk factor for atherosclerosis and subsequent cardiovascular disease (32, 33) .
As master regulators in many cellular processes initiated by vascular injury, miRNAs can be crucial actors in vRTx. miRNAs play a crucial role in the DNA damage 
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Eken et al. In contrast to C-reactive protein, PTX3 is evolutionarily well conserved (45) and expressed within the vasculature, making it a good target to study in humans as well as animal models within this context.
Interestingly, PTX3 has inflammatory as well as regulatory capacities, as its release induces both proinflammatory and anti-inflammatory signaling (46, 47) .
PTX3 is a validated target of miR-29b (48) and a key regulatory protein in pathophysiological processes in which innate immunity, inflammation, and extracellular matrix remodeling intersect (45) .
In vRTx, we have previously described sustained high expression of PTX3 mRNA at earlier time points after radiotherapy (24) . The current study is the first to describe gene expression patterns in irradiated human arteries at a median of >2 years after radio- Remlarsen) is ongoing in cutaneous fibrotic disorders. Here, mimics are being applied topically to the skin, which limits undesired off-target effects in organ systems in which systemically administered miRNA modulators assimilate to a much higher degree (e.g., liver, kidney). For the treatment of vascular diseases, cell type-specific or local ways of delivery (using stents and balloons) could limit off-target effects, while triggering local uptake and efficiency of these potent therapies. Eken et al.
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